Guangzhou Wondfo Biotech Co., Ltd (SHE: 300482), a biotechnology firm based in China, has formalized a partnership with the University of Science, Malaysia (USM). The collaboration aims to enhance academic exchange and scientific translation efforts, among other initiatives. Financial details of the agreement were not disclosed.
This strategic partnership builds upon an initial collaboration that began in 2022, focusing on the application of Point-of-Care Testing (POCT) in the management of severe diseases. The expanded cooperation is expected to leverage the respective strengths of Wondfo Biotech and USM to advance research and development in the medical field.- Flcube.com
